LUND-JURGENSEN KIRSTEN 4
4 · PFIZER INC · Filed Feb 27, 2018
Insider Transaction Report
Form 4
PFIZER INCPFE
LUND-JURGENSEN KIRSTEN
Executive Vice President
Transactions
- Sale
Common Stock
2018-02-26$37.19/sh−9,510$353,677→ 17,770 total - Exercise/Conversion
Common Stock
2018-02-24$18.90/sh+15,957$301,587→ 36,959 total - Tax Payment
Common Stock
2018-02-24$36.26/sh−3,692$133,872→ 33,267 total - Tax Payment
Common Stock
2018-02-24$35.98/sh−5,091$183,174→ 28,176 total - Tax Payment
Common Stock
2018-02-26$37.09/sh−896$33,233→ 27,280 total - Exercise/Conversion
Stock Appreciation Rights
2018-02-24−15,957→ 0 totalExercise: $18.90From: 2018-02-24Exp: 2018-02-24→ Common Stock (15,957 underlying)
Footnotes (6)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]Price is the closing price of Pfizer common stock on February 23, 2018
- [F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
- [F6]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).